EN
enGene Holdings Inc. Warrants
ENGNW · NASDAQ
$0.20 -90.48% (-$1.90)
1M -53.50%
Market Cap $10.8M
P/E Ratio -
Div. Yield -
ROE 2.10%
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/B 0.05x
P/E N/A
EV/EBITDA N/A
Growth
78 /100
Growing Book val. growth 9.59%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
FCF margin N/A
Quality
0 /100
Poor ROIC 1.61%
ROE 2.10%
Asset turnover 0.00x
Debt
69 /100
Low Debt/Equity 0.03x
Current ratio 9.79x
Int. coverage -44.28x
Stability
19 /100
Unstable Beta -0.28x
EPS volatility 128,900.54%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ENGNW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Ronald H. W. Cooper
Employees
82
Headquarters
Montreal
Upcoming events
23 DEC
Earnings
Upcoming earnings report